162010-78-8

Basic information

• Product Name: Benzoic acid, 4-(chlorosulfonyl)-3-nitro-, methyl ester
• CAS NO: 162010-78-8
• Molecular Formula: C8H6ClNO6S
• Molecular Weight: 279.658
• Mol File: 162010-78-8.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-(chlorosulfonyl)-3-nitro-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-(chlorosulfonyl)-3-nitro-, methyl ester(162010-78-8)
• EPA Substance Registry System: Benzoic acid, 4-(chlorosulfonyl)-3-nitro-, methyl ester(162010-78-8)

Safety Data

• Hazardous Substances Data: 162010-78-8(Hazardous Substances Data)

Upstream product

• 14719-83-6 methyl 3-nitro-4-chlorobenzoate 
• 329-59-9 4-fluoro-3-nitro-benzoic acid methyl ester 
• 59515-34-3 4-mercapto-3-nitro-benzoic acid methyl ester 

Downstream Products

• 263758-25-4 C₂₂H₂₅⁽²⁾H₂N₃O₈S 
• 2243162-67-4 C₁₉H₂₁N₃O₆S 
• 199535-36-9 3-Amino-4-sulfamoyl-benzoic acid methyl ester 
• 162010-79-9 4-(Aminosulfonyl)-3-nitrobenzenecarboxylic acid, methyl ester 
• 263758-27-6 C₂₂H₂₇N₃O₈S 
• 263758-26-5 C₂₁H₂₃⁽²⁾H₂N₃O₈S 
• 197728-18-0 4-(4-Methyl-benzylsulfamoyl)-3-nitro-benzoic acid 
• 330798-32-8 methyl 4-[([3-(9-anthryl)propyl]{2-[(tert-butoxycarbonyl)(d³-methyl)amino]ethyl}amino)sulphonyl]-3-nitrobenzoate 
• 330798-31-7 methyl 4-[([3-(9-anthryl)propyl]{2-[(tert-butoxycarbonyl)(methyl)amino]ethyl}amino)sulphonyl]-3-nitrobenzoate 
• 575434-16-1 methyl 4-(3-tert-butoxycarbonylaminopropylsulfamoyl)-3-nitrobenzoate 
• 321352-71-0 4-{3-(3-tert-butoxycarbonylamino-prop-1-ynyl)-4-methoxy-5-[3-(2,2,2-trifluoro-acetylamino)-prop-1-ynyl]-phenylsulfamoyl}-3-nitro-benzoic acid methyl ester 

Relevant articles and documents

Utility of the 2-Nitrobenzenesulfonamide Group as a Chemical Linker for Enhanced Extracellular Stability and Cytosolic Cleavage in siRNA-Conjugated Polymer Systems

Herein we report the 2-nitrobenzenesulfonamide group as a new chemical linker that responds to the difference in redox potential across the cellular membrane, toward the construction of siRNA–polymer conjugates. PEG-conjugated to siRNA via the 2-nitrobenz

INDOLE DERIVATIVE USED AS CRTH2 INHIBITOR

The present application discloses an indole as represented by formula (I) used as a CRTH2 inhibitor, and a pharmaceutically acceptable salt or tautomer of the indole, and an application of same in treating a disease related to a CRTH2 receptor.

Novel Sulfonaminoquinoline Hepcidin Antagonists

The present invention relates to novel hepcidin antagonists, pharmaceutical compositions comprising them and the use thereof as medicaments for the use in the treatment of iron metabolism disorders, such as, in particular, iron deficiency diseases and anemias, in particular anemias in connection with chronic inflammatory diseases.